FTXH

First Trust Nasdaq Pharmaceuticals ETF [FTXH] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

FTXH Stock Summary

Top 10 Correlated ETFs

FTXH

Top 10 Correlated Stocks

FTXH

In the News

FTXH Financial details

Company Rating
-
Market Cap
20.56M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.1
Dividend %
1.51%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
3.7%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
23.85-28.41
52W High
-2.89%
52W Low
+18.22%
RSI
38
Rel Volume
0.22
Avg Volume
5.87K
Volume
1.28K
Perf Week
-3.51%
Perf Month
-0.59%
Perf Quarter
-4.06%
Perf Half Y
-5.26%
-
-
-
-
Beta
0.56
-
-
Volatility
0.36%, 0.39%
Prev Close
-0.29%
Price
27.19
Change
-0.59%

FTXH Financial Performance

FTXH Dividend History

FTXH Frequently Asked Questions

What is First Trust Nasdaq Pharmaceuticals ETF stock symbol ?

First Trust Nasdaq Pharmaceuticals ETF is a US stock and trading under the symbol FTXH

What is First Trust Nasdaq Pharmaceuticals ETF stock quote today ?

First Trust Nasdaq Pharmaceuticals ETF stock price is $27.19 today.

Is First Trust Nasdaq Pharmaceuticals ETF stock public?

Yes, First Trust Nasdaq Pharmaceuticals ETF is a publicly traded company.

Something similar

Top by Market Cap
BRK-B
FXAIX
BRK-A
LLY
TL0.DE
Top Correlated ETFs
FHI.TO
PPH
Top Correlated Stocks
PFE
CRL
UPS
6MK.DE
0R08.L
Similar Market Cap
MTR.L
XBAK.L
FHF.TO
GFAIW
NLH.V

Company Profile

Financial Services Asset Management
  • Volume Average 5.87K
  • Market Capitalization 20.56M
  • Headquarters US
  • IPO Date 2016-09-22

The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.